Profit & Loss
Market Updates
>
Equity
>
Corporate Information
>
Profit & Loss
Back To Homepage
As on (04 Aug 2025 | 11:18)
Back To Homepage
As on (04 Aug 2025 | 11:18)
Daily Market Tracker
News
Corporate Information
Corporate Action
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Profit & Loss
Quarterly Results
Financial Ratios
Historical Price
Director's Report
Score Board
MF Holdings
Name Change
Company News
Beta Value
Peer Comparison
Prev Quarter Comparison
Dividend Details
Balance Sheet
Share Holding Pattern
Technical Charts
Details-quote
Abbott India Ltd
Pharmaceuticals - Multinational
BSE Code
500488
ISIN Demat
INE358A01014
Book Value
1,992.07
NSE Symbol
ABBOTINDIA
Div & Yield %
1.41
Market Cap (
₹
Cr.)
71561.5
P/E
50.58
EPS
665.85
Face Value
10
Particulars
Mar2025(
₹
)
Mar2024(
₹
)
Mar2023(
₹
)
Mar2022(
₹
)
Mar2021(
₹
)
Mar2020(
₹
)
INCOME :
Sales Turnover
6,445.79
5,875.26
5,379.08
4,932.57
4,310.02
4,093.14
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
6,445.79
5,875.26
5,379.08
4,932.57
4,310.02
4,093.14
Other Income
275.58
248.27
154.15
83.16
80.90
114.39
Stock Adjustments
180.68
-7.73
-66.09
22.28
104.00
-61.24
Total Income
6,902.05
6,115.80
5,467.14
5,038.01
4,494.92
4,146.29
EXPENDITURE :
Raw Materials
3,677.46
3,212.88
2,908.97
2,679.49
2,494.92
2,254.39
Power & Fuel Cost
15.43
16.63
17.15
14.98
12.74
13.73
Employee Cost
587.54
576.58
563.59
579.46
492.65
476.11
Other Manufacturing Expenses
134.09
126.47
79.99
59.82
49.66
49.84
Selling & Administrative Expenses
448.84
429.89
467.74
459.18
366.98
400.27
Miscellaneous Expenses
68.51
51.98
69.92
80.15
75.61
81.11
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
4,931.87
4,414.43
4,107.36
3,873.08
3,492.56
3,275.45
Operating Profit
1,970.18
1,701.37
1,359.78
1,164.93
1,002.36
870.84
Interest
11.43
12.45
15.99
19.10
18.28
8.53
Gross Profit
1,958.75
1,688.92
1,343.79
1,145.83
984.08
862.31
Depreciation
71.80
71.17
69.97
66.10
58.13
59.61
Profit Before Tax
1,886.95
1,617.75
1,273.82
1,079.73
925.95
802.70
Tax
469.79
415.46
325.60
281.16
239.05
208.29
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
2.72
1.07
-1.19
-0.13
-3.79
1.48
Reported Net Profit
1,414.44
1,201.22
949.41
798.70
690.69
592.93
Extraordinary Items
-0.48
0.12
-0.19
0.00
-0.18
-0.41
Adjusted Net Profit
1,414.92
1,201.10
949.60
798.70
690.87
593.34
Adjustment below Net Profit
0.00
0.00
0.00
0.00
0.00
-35.51
P & L Balance brought forward
2,819.01
2,428.51
2,158.40
2,023.93
1,933.54
1,573.53
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
1,012.67
810.72
679.30
664.23
600.30
197.41
P & L Balance carried down
3,220.78
2,819.01
2,428.51
2,158.40
2,023.93
1,933.54
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
4,750.00
4,100.00
3,250.00
2,750.00
2,750.00
2,500.00
Dividend Per Share(Rs)
475.00
410.00
325.00
275.00
275.00
250.00
Earnings Per Share-Unit Curr
665.62
565.28
446.78
375.86
325.03
279.03
Earnings Per Share(Adj)-Unit Curr
665.62
565.28
446.78
375.86
325.03
279.03
Book Value-Unit Curr
1,992.07
1,740.65
1,500.49
1,326.96
1,224.55
1,144.33
Book Value(Adj)-Unit Curr
1,992.07
1,740.65
1,500.49
1,326.96
1,224.55
1,144.33